Paper12372300
Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage.
Deverman BE and 11 others. Cell, 2002. Cited by 206 papers, by iCite.
Cite this record
ConductScience Library. Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Papers, record 12372300. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12372300
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA Damage | Major topic |
| Gene Expression Regulation | Major topic |
| Proto-Oncogene Proteins c-bcl-2 | Major topic |
| Amino Acid Sequence | |
| Antineoplastic Agents | |
| Apoptosis | |
| Asparagine | |
| Cisplatin | |
| Dose-Response Relationship, Drug | |
| Fibroblasts | |
| Humans | |
| Immunoblotting | |
| Microscopy, Fluorescence | |
| Molecular Sequence Data | |
| Oligonucleotides, Antisense | |
| Peptides | |
| Plasmids | |
| Protein Structure, Tertiary | |
| Sequence Homology, Amino Acid | |
| Time Factors | |
| Transfection | |
| Tumor Cells, Cultured | |
| bcl-X Protein |
Source PubMed
Cited by100
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 206 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42901888 | BH3 profiling analyses for functional precision medicine. | Oncogenesis | 2026 | https://conductscience.org/library/papers/42901888 | PubMed |
| 42236666 | Anti-apoptotic BCL-2 family proteins: from regulatory networks to therapeutic targeting. | Oncogenesis | 2026 | https://conductscience.org/library/papers/42236666 | PubMed |
| 41954119 | Expanding the Chemoproteomic Toolkit to Asparagine and Glutamine. | ACS Chem Biol | 2026 | https://conductscience.org/library/papers/41954119 | PubMed |
| 41775691 | Mesenchymal stromal cells modulate survival and regeneration of human hematopoietic stem cells via PGE2/cAMP signaling. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41775691 | PubMed |
| 41596764 | BCL-2 and BCL-xL in Cancer: Regulation, Function, and Therapeutic Targeting. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596764 | PubMed |
| 40817599 | H1N76/77 deamidation facilitates chromatin remodelling and genome stability during DNA damage repair. | Clin Transl Med | 2025 | https://conductscience.org/library/papers/40817599 | PubMed |
| 40725067 | Investigation of the Effect of C-Terminal Adjacent Phenylalanine Residues on Asparagine Deamidation by Quantum Chemical Calculations. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40725067 | PubMed |
| 40559997 | Advances in the Study of Protein Deamidation: Unveiling Its Influence on Aging, Disease Progression, Forensics and Therapeutic Efficacy. | Proteomes | 2025 | https://conductscience.org/library/papers/40559997 | PubMed |
| 40362380 | The Unified Theory of Neurodegeneration Pathogenesis Based on Axon Deamidation. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40362380 | PubMed |
| 40287848 | Multi-omics Analysis Sheds Light on the Extracellular Role of PCMT1. | J Proteome Res | 2025 | https://conductscience.org/library/papers/40287848 | PubMed |
| 40240600 | Histone H1 deamidation facilitates chromatin relaxation for DNA repair. | Nature | 2025 | https://conductscience.org/library/papers/40240600 | PubMed |
| 39894946 | Semisynthesis of Isomerized Histone H4 Reveals Robustness and Vulnerability of Chromatin toward Molecular Aging. | J Am Chem Soc | 2025 | https://conductscience.org/library/papers/39894946 | PubMed |
| 39702829 | Kinetic, thermodynamic, and ab initio insights of AsnGly isomerisation as a ticking time bomb for protein integrity. | Commun Chem | 2024 | https://conductscience.org/library/papers/39702829 | PubMed |
| 37987246 | Atypical Asparagine Deamidation of NW Motif Significantly Attenuates the Biological Activities of an Antibody Drug Conjugate. | Antibodies (Basel) | 2023 | https://conductscience.org/library/papers/37987246 | PubMed |
| 37371456 | Bcl-xL Is Spontaneously Inserted into Preassembled Nanodiscs and Stimulates Bax Insertion in a Cell-Free Protein Synthesis System. | Biomolecules | 2023 | https://conductscience.org/library/papers/37371456 | PubMed |
| 37070640 | PIMT is a novel and potent suppressor of endothelial activation. | Elife | 2023 | https://conductscience.org/library/papers/37070640 | PubMed |
| 35915613 | Inhibition of c-MYC-miRNA 19 Pathway Sensitized CML K562 Cells to Etoposide via NHE1 Upregulation. | Oxid Med Cell Longev | 2022 | https://conductscience.org/library/papers/35915613 | PubMed |
| 34601571 | Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2. | Blood | 2022 | https://conductscience.org/library/papers/34601571 | PubMed |
| 34593755 | Exposure of a specific pleioform of multifunctional glyceraldehyde 3-phosphate dehydrogenase initiates CD14-dependent clearance of apoptotic cells. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/34593755 | PubMed |
| 34179092 | A Comprehensive Analysis of the Downregulation of miRNA-1827 and Its Prognostic Significance by Targeting SPTBN2 and BCL2L1 in Ovarian Cancer. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/34179092 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| BCL2L1 | 598 | PubTator's text mining | https://conductscience.org/library/genes/598 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12372300
GET https://conductscience.org/api/papers/v1/12372300/cited_by?page=2